JP2022525038A5 - - Google Patents
Info
- Publication number
- JP2022525038A5 JP2022525038A5 JP2021553059A JP2021553059A JP2022525038A5 JP 2022525038 A5 JP2022525038 A5 JP 2022525038A5 JP 2021553059 A JP2021553059 A JP 2021553059A JP 2021553059 A JP2021553059 A JP 2021553059A JP 2022525038 A5 JP2022525038 A5 JP 2022525038A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- pharmaceutically acceptable
- acceptable salt
- alkynyl
- alkenyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962815735P | 2019-03-08 | 2019-03-08 | |
| US62/815,735 | 2019-03-08 | ||
| PCT/US2020/021670 WO2020185661A1 (en) | 2019-03-08 | 2020-03-09 | Use of 8,9-dihydrocannabidiol compounds |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022525038A JP2022525038A (ja) | 2022-05-11 |
| JP2022525038A5 true JP2022525038A5 (https=) | 2023-03-16 |
| JP7620984B2 JP7620984B2 (ja) | 2025-01-24 |
Family
ID=72426794
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021553059A Active JP7620984B2 (ja) | 2019-03-08 | 2020-03-09 | ８，９－ジヒドロカンナビジオール化合物の使用 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20250152520A2 (https=) |
| EP (1) | EP3935037A4 (https=) |
| JP (1) | JP7620984B2 (https=) |
| CN (1) | CN113874344B (https=) |
| AU (1) | AU2020236953A1 (https=) |
| BR (1) | BR112021017661A2 (https=) |
| CA (1) | CA3132841A1 (https=) |
| WO (1) | WO2020185661A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2021150885A1 (en) * | 2020-01-24 | 2021-07-29 | Perkinelmer Health Sciences, Inc. | Cannabinoid derivatives |
| CN114507153B (zh) * | 2020-11-17 | 2025-06-24 | 中国科学院上海药物研究所 | 一类间苯二酚化合物及其制备方法以及在神经系统疾病中的应用 |
| CN113372196B (zh) * | 2021-07-02 | 2022-09-30 | 江南大学 | 8,9-二氢大麻二酚及其合成方法与应用 |
| WO2024006896A1 (en) * | 2022-06-29 | 2024-01-04 | The Regents Of The University Of California | Uses of hydrogenated cannabidiol (h4cbd) and advanced metabolic syndrome |
| AU2024359022A1 (en) * | 2023-10-10 | 2026-04-09 | Jazz Pharmaceuticals Research Uk Limited | Cannabinoid compounds and uses thereof |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4018777A (en) * | 1975-11-14 | 1977-04-19 | Abbott Laboratories | 2-Substituted-5-alkyl resorcinols |
| TWI583374B (zh) | 2010-03-30 | 2017-05-21 | Ｇｗ伐瑪有限公司 | 使用植物大麻素次大麻二酚（ｃｂｄｖ）來治療癲癇之用途 |
| GB2530001B (en) * | 2014-06-17 | 2019-01-16 | Gw Pharma Ltd | Use of cannabidiol in the reduction of convulsive seizure frequency in treatment-resistant epilepsy |
| CN108024973A (zh) * | 2015-07-16 | 2018-05-11 | 耶路撒冷希伯来大学伊森姆研究发展有限公司 | 氟化的cbd化合物、其组合物以及用途 |
| CN108785298A (zh) * | 2017-04-27 | 2018-11-13 | 汉义生物科技（北京）有限公司 | 一种用于治疗癫痫的药物组合物、其制备方法及用途 |
| CN109106699A (zh) * | 2017-06-23 | 2019-01-01 | 汉义生物科技（北京）有限公司 | 一种用于治疗癫痫的药物组合物、其制备方法及用途 |
-
2020
- 2020-03-09 CA CA3132841A patent/CA3132841A1/en active Pending
- 2020-03-09 BR BR112021017661A patent/BR112021017661A2/pt unknown
- 2020-03-09 WO PCT/US2020/021670 patent/WO2020185661A1/en not_active Ceased
- 2020-03-09 AU AU2020236953A patent/AU2020236953A1/en not_active Abandoned
- 2020-03-09 CN CN202080030186.9A patent/CN113874344B/zh active Active
- 2020-03-09 EP EP20769683.2A patent/EP3935037A4/en active Pending
- 2020-03-09 US US17/436,015 patent/US20250152520A2/en active Pending
- 2020-03-09 JP JP2021553059A patent/JP7620984B2/ja active Active